Harding Loevner LP lowered its stake in shares of Monsanto Co. (NYSE:MON) by 0.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,061,856 shares of the company’s stock after selling 2,693 shares during the period. Harding Loevner LP owned 0.24% of Monsanto worth $108,522,000 as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in MON. WFG Advisors LP increased its stake in Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock valued at $104,000 after buying an additional 158 shares during the period. Signaturefd LLC increased its stake in Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock valued at $112,000 after buying an additional 415 shares during the period. Mycio Wealth Partners LLC increased its stake in Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares during the period. Pinkerton Retirement Specialists LLC increased its stake in Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock valued at $114,000 after buying an additional 1,014 shares during the period. Finally, Enterprise Financial Services Corp increased its stake in Monsanto by 4.5% in the second quarter. Enterprise Financial Services Corp now owns 1,335 shares of the company’s stock valued at $138,000 after buying an additional 57 shares during the period. 78.26% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Monsanto Co. (NYSE:MON) traded up 0.11% during trading on Monday, reaching $101.32. The company had a trading volume of 1,458,273 shares. The firm’s 50 day moving average price is $101.11 and its 200 day moving average price is $103.79. The firm has a market capitalization of $44.38 billion, a PE ratio of 33.91 and a beta of 1.01. Monsanto Co. has a 12-month low of $83.73 and a 12-month high of $114.26.

Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.02) by $0.09. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The company earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. During the same period in the prior year, the firm earned ($0.19) earnings per share. Monsanto’s revenue was up 8.8% on a year-over-year basis. Equities research analysts forecast that Monsanto Co. will post $4.73 EPS for the current year.

Several research firms recently weighed in on MON. Goldman Sachs Group Inc. raised Monsanto from a “sell” rating to a “neutral” rating and set a $104.00 price objective on the stock in a report on Tuesday, September 27th. Piper Jaffray Cos. set a $128.00 target price on Monsanto and gave the stock a “buy” rating in a research report on Thursday, September 15th. Argus reaffirmed a “buy” rating and set a $128.00 target price on shares of Monsanto in a research report on Sunday, October 9th. Jefferies Group reaffirmed a “buy” rating on shares of Monsanto in a research report on Tuesday, September 6th. Finally, Citigroup Inc. raised their target price on Monsanto from $112.00 to $116.00 and gave the stock a “neutral” rating in a research report on Friday, August 19th. Three analysts have rated the stock with a sell rating, eight have given a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $114.65.

In other Monsanto news, EVP Kerry J. Preete sold 2,745 shares of the firm’s stock in a transaction that occurred on Thursday, November 17th. The shares were sold at an average price of $100.96, for a total transaction of $277,135.20. Following the completion of the transaction, the executive vice president now owns 50,056 shares of the company’s stock, valued at $5,053,653.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert T. Fraley sold 80,631 shares of the firm’s stock in a transaction that occurred on Friday, October 14th. The shares were sold at an average price of $102.04, for a total transaction of $8,227,587.24. Following the transaction, the executive vice president now directly owns 38,711 shares of the company’s stock, valued at approximately $3,950,070.44. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by corporate insiders.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.